| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |